Form 4 Tracker
NEUROCRINE BIOSCIENCES INC
NBIX

54 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 10, 2025Feb 10 9:33 PMJULIE SMITH COOKE
Proposed Sale
700$122.62$85.8K

View →

Feb 10, 2025Feb 10 9:33 PMDAVID WARREN BOYER
Proposed Sale
700$122.62$85.8K

View →

Feb 10, 2025Feb 10 9:32 PMERIC BENEVICH
Proposed Sale
980$122.62$120.2K

View →

Feb 10, 2025Feb 10 9:32 PMKEVIN CHARLES GORMAN
Proposed Sale
2,274$122.62$278.8K

View →

Feb 10, 2025Feb 10 9:32 PMDARIN LIPPOLDT
Proposed Sale
911$122.62$111.7K

View →

Feb 10, 2025Feb 10 9:31 PMEIRY WYN ROBERTS
Proposed Sale
980$122.62$120.2K

View →

Feb 10, 2025Feb 10 9:30 PMMATTHEW C ABERNETHY
Proposed Sale
980$122.62$120.2K

View →

Feb 3, 2025Feb 3 9:19 PMINGRID DELAET
Proposed Sale
623$151.82$94.6K

View →

Jan 31, 2025Jan 31 9:34 PMJULIE COOKE
Proposed Sale
824$153.29$126.3K

View →

Jan 31, 2025Jan 31 9:33 PMKEVIN CHARLES GORMAN
Proposed Sale
2,707$153.29$415.0K

View →

Jan 31, 2025Jan 31 9:32 PMEIRY WYN ROBERTS
Proposed Sale
1,457$153.29$223.3K

View →

Jan 31, 2025Jan 31 9:32 PMINGRID DELAET
Proposed Sale
422$153.29$64.7K

View →

Jan 31, 2025Jan 31 9:31 PMKYLE GANO
Proposed Sale
1,541$153.29$236.2K

View →

Jan 31, 2025Jan 31 9:29 PMMATTHEW C ABERNETHY
Proposed Sale
1,283$153.29$196.7K

View →

Jan 31, 2025Jan 31 9:29 PMERIC BENEVICH
Proposed Sale
1,207$153.29$185.0K

View →

Jan 31, 2025Jan 31 9:28 PMDAVID WARREN BOYER
Proposed Sale
1,104$153.29$169.2K

View →

Jan 31, 2025Jan 31 9:28 PMDARIN LIPPOLDT
Proposed Sale
1,250$153.29$191.6K

View →

Jan 31, 2025Jan 31 9:28 PMJULIE COOKE
Proposed Sale
916$153.29$140.4K

View →

Jan 31, 2025Jan 31 9:27 PMJUDE ONYIA
Proposed Sale
126$153.29$19.3K

View →

Jan 27, 2025Jan 27 9:27 PMKEVIN CHARLES GORMAN
Proposed Sale
146,105$148.73$21.7M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 21, 2026May 21 11:24 PMWilliam H RastetterDirector
Option Exercise
3,3180(D)

View →

May 21, 2026May 21 11:23 PMPOPS RICHARD FDirector
Option Exercise
3,3180(D)

View →

May 21, 2026May 21 11:22 PMChristine A PoonDirector
Option Exercise
3,3180(D)

View →

May 21, 2026May 21 11:22 PMLeslie V NorwalkDirector
Option Exercise
1,6590(D)

View →

May 21, 2026May 21 11:21 PMMORROW GEORGE JDirector
Option Exercise
3,3180(D)

View →

May 21, 2026May 21 11:21 PMJohanna MercierDirector
Option Exercise
3,3180(D)

View →

May 21, 2026May 21 11:21 PMLYONS GARY ADirector
Option Exercise
1,6590(D)

View →

May 19, 2026May 21 9:49 PMKevin Charles GormanDirector
Option Exercise
205,088$43.240(D)

View →

May 15, 2026May 18 9:50 PMPOPS RICHARD FDirector
Option Exercise
15,000$47.890(D)

View →

Feb 13, 2026Feb 17 10:49 PMMatt AbernethyChief Financial Officer
Option Exercise
4,8072,566(D)

View →

Feb 13, 2026Feb 17 10:49 PMMatt AbernethyChief Financial Officer
Grant/Award
51,830$124.127,735(D)

View →

Feb 12, 2026Feb 17 10:49 PMMatt AbernethyChief Financial Officer
Option Exercise
2,1336,401(D)

View →

Feb 13, 2026Feb 17 10:48 PMDavid W. BoyerChief Corp. Affairs Officer
Option Exercise
3,3521,812(D)

View →

Feb 13, 2026Feb 17 10:48 PMDavid W. BoyerChief Corp. Affairs Officer
Grant/Award
36,713$124.125,479(D)

View →

Feb 12, 2026Feb 17 10:48 PMDavid W. BoyerChief Corp. Affairs Officer
Option Exercise
1,6004,801(D)

View →

Feb 13, 2026Feb 17 10:48 PMKyle GanoDirector, Chief Executive Officer
Option Exercise
4,8072,566(D)

View →

Feb 13, 2026Feb 17 10:48 PMKyle GanoDirector, Chief Executive Officer
Grant/Award
134,972$124.1220,142(D)

View →

Feb 12, 2026Feb 17 10:48 PMKyle GanoDirector, Chief Executive Officer
Option Exercise
4,90714,721(D)

View →

Feb 13, 2026Feb 17 10:47 PMJude OnyiaChief Scientific Officer
Grant/Award
64,788$124.129,669(D)

View →

Feb 13, 2026Feb 17 10:47 PMJude OnyiaChief Scientific Officer
Option Exercise
5,4072,717(D)

View →